Purple Biotech Ltd
PPBT
$2.99
$0.072.40%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | 59.00K | -- | -- | 62.00K | |
| Gross Profit | -59.00K | -- | -- | -62.00K | |
| SG&A Expenses | 1.08M | 683.00K | 646.00K | 496.00K | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 2.96M | 1.24M | 1.41M | 1.02M | |
| Operating Income | -2.96M | -1.24M | -1.41M | -1.02M | |
| Income Before Tax | -23.64M | -1.09M | -456.00K | -415.00K | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -23.64M | -1.09M | -456.00K | -415.00K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 97.00K | 4.00K | 3.00K | 5.00K | |
| Net Income | -23.55M | -1.09M | -453.00K | -410.00K | |
| EBIT | -2.96M | -1.24M | -1.41M | -1.02M | |
| EBITDA | -2.91M | -1.19M | -1.36M | -1.01M | |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | |
| Normalized Basic EPS | 0.00 | 0.00 | -- | 0.00 | |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | |
| Normalized Diluted EPS | 0.00 | 0.00 | -- | 0.00 | |
| Average Basic Shares Outstanding | 2.38B | 547.24M | 526.45M | 410.26M | |
| Average Diluted Shares Outstanding | 2.38B | 547.24M | 526.45M | 410.26M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |